Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | 1.96% | 81.05 | 0.7% | $1593.78m | |
| JNJ | Johnson & Johnson | -0.09% | 163.72 | 0.7% | $1029.28m | |
| PFE | Pfizer Inc. | 1.76% | 42.83 | 0.9% | $940.36m | |
| ABBV | AbbVie, Inc. | 0.97% | 108.49 | 1.9% | $680.09m | |
| BMY | Bristol-Myers Squibb Co. | 0.87% | 58.09 | 1.0% | $658.95m | |
| LLY | Eli Lilly & Co. | 0.64% | 243.85 | 1.1% | $610.94m | |
| AZN | AstraZeneca Plc | 0.77% | 60.63 | 1.0% | $366.84m | |
| NVS | Novartis AG | 1.61% | 84.49 | 0.2% | $176.86m | |
| GSK | GlaxoSmithKline Plc | 0.74% | 39.46 | 0.2% | $161.96m | |
| RGEN | Repligen Corp. | 2.13% | 268.25 | 6.8% | $118.08m | |
| AVIR | Atea Pharmaceuticals, Inc. | -4.20% | 13.24 | 0.3% | $116.76m | |
| VTRS | Viatris, Inc. | 3.10% | 13.99 | 0.0% | $92.80m | |
| NVO | Novo Nordisk A/S | -0.09% | 104.56 | 0.1% | $91.61m | |
| EDSA | Edesa Biotech, Inc. | -0.97% | 8.14 | 0.0% | $73.37m | |
| SNY | Sanofi | 2.06% | 49.05 | 0.2% | $64.75m |
Company Profile
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.